Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ENOXAPARIN SODIUM
- Effectiveness & Safety of Ovine Enoxaparin Sodium to Originator Enoxaparin in Non-ST-Segment Elevation Acute Coronary Syndrome (NSTEACS) Patients: a Multicenter, Non-randomized, Open-label, Non-inferiority Trial
- THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)
- Prevention of Thromboembolism Using Apixaban vs Enoxaparin Following Spinal Cord Injury
- Bivalirudin Versus Enoxaparin in Critically Ill COVID-19 Patients
- Bioequivalence Study of a Generic Enoxaparin Sodium to Clexane® After Single Subcutaneous Dose in Healthy Human Subjects
- Clinical Trial of Dimolegin (DD217) in Prevention of Thrombotic Complications in Patients With COVID-19
- Pre-operative Enoxaparin in the Surgical Management of Multi-trauma Patients Undergoing Orthopedic Surgical Procedures
- Effects of Low Molecular Weight Heparin Therapy With Soft-Mist Inhaler for COVID-19 Induced Hypoxemia
- Low-Dose Tenecteplase in Covid-19 Diagnosed With Pulmonary Embolism
- Anticoagulation in Critically Ill Patients With COVID-19 (The IMPACT Trial)
- Pharmacodynamic Equivalence of Ovine Enoxaparin to Lovenox®
- Protective Effect of Aspirin on COVID-19 Patients
- Study of Pharmacodynamic Equivalence of Enoxaparin Rovi to Clexane®, in Healthy Volunteers
- Pilot Feasibility and Safety of Administering Weight Adjusted Fixed LMWH Dose
- Comparison of Thromboembolic Events in Patients Undergoing Thromboprophylactic Treatment With ENOXA® vs Lovenox®
- Local Uterine Application of Low Molecular Weight Heparin (LMWH) in Intra-cytoplasmic Sperm Injection (ICSI)
- Bioavailability Study of Enoxaparin Sodium Chemi and Clexane s.c.
- Full Dose Tenecteplase (TNK-tPA) Together With Heparin Sodium, Full Dose Tenecteplase With Enoxaparin, Half Dose Tenecteplase Together With Abciximab and Heparin Sodium in Patients With Acute Myocardial Infarction (AMI)
- Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
- Efficacy of Bemiparin Versus Enoxaparin in the Treatment of DVT
- Aspirin and Compression Devices for VTE Prophylaxis in Orthopaedic Oncology
- Low Molecular Weight Heparin in Recurrent Miscarriage With Negative Antiphospholipid Antibodies
- Low Molecular Weight Heparin for Hemodialysis Anticoagulation
- Prophylactic Use of Sodium Enoxaparin for Venous Thromboembolism in High-Risk Abdominal Surgery
- A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty
- A Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty
- Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Hip Fracture Surgery
- A Phase 3 Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty
- Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary Embolism
- A Randomized Study to Evaluate the Effect of Two Different Doses of Enoxaparin Sodium in Combination With Standard Chemotherapy in Patients With Stage Small Cell Lung Cancer (SCLC)
- Adjunctive Cilostazol Versus High Maintenance-dose ClopidogrEL in Acute Myocardial Infarction (AMI) Patients According to CYP2C19 Polymorphism
- Comparing Enoxaparin to Fondaparinux to Prevent Venous Thromboembolism (VTE) in Bariatric Surgical Patients
- Japanese Efficacy and Safety Study of Enoxaparin in Patients With Curative Abdominal Cancer Surgery
- Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Hip Fracture Surgery
- Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Elective Knee Replacement Surgery
- Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients With Restricted Mobility
- Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Total Hip Replacement Surgery
- Japanese Safety and Efficacy Study of Enoxaparin in Patients With Hip Fracture Surgery
- Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery
- Total Hip Replacement Study With XRP4563 (Enoxaparin Sodium)
- Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement Surgery
- Assessment of Cardioversion Using Transesophageal Echocardiography II (ACUTE II)
- The Effect of Enoxaparin Sodium on the Incidence of Deep Vein Thrombosis Following Electrophysiology Studies and Radiofrequency Ablation.
- Adjuvant Treatment of Pulmonary Embolism With Drotrecogin Alfa (Activated): Phase II Exploratory Study
- Safety and Efficacy of Enoxaparin in Percutaneous Coronary Intervention (PCI) Patients, an International Randomized Evaluation (STEEPLE)
- Enoxaparin Versus Unfractionated Heparin in Subjects Who Present to the Emergency Department With Acute Coronary Syndrome (RESCUE)
- PREVAIL: PREvention of VTE After Acute Ischemic Stroke With LMWH Enoxaparin ( - VTE: Venous Thromboembolism - LMWH: Low Molecular Weight Heparin)
- EXCLAIM:Extended Prophylaxis for Venous ThromboEmbolism (VTE) in Acutely Ill Medical Patients With Prolonged Immobilization
Clinical trials list
click for details